Effects of Nebivolol on Exercise Tolerance and Left Ventricular Systolic and Diastolic Function

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2013

Study Completion Date

May 31, 2014

Conditions
Hypertension
Interventions
DRUG

Nebivolol

Initial dose of 5 mg titrated (doubling of previous dose) to optimal blood pressure. The dose was titrated by doubling the previous dosage to achieve BP less than or equal to 130/80 mm Hg at 2 weeks and 4 weeks. The mean dose of nebivolol used week 4 through week 10 was 7.8 mg. It should be noted that nebivolol was added to the subject's existing stable antihypertensive regimen which included a mean of 2 other medications.

Trial Locations (1)

63141

St. John's Mercy Cardiovascular Research, St Louis

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Mercy Research

OTHER